alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>   1

                                                                     EXHIBIT 5.1

                        [Letterhead of McCarthy Tetrault]

                                October 28, 1998



Securities and Exchange Commission
450 Fifth Street NW
Washington, DC  20549

Dear Sirs/Mesdames:

           Re:     Registration Statement on Form S-8 of Intrawest Corporation;
                   Intrawest Corporation Stock Option Plan

           We have acted as Canadian counsel to Intrawest Corporation (the
"Company") in connection with the filing of the above-referenced Registration
Statement (the "Registration Statement") relating to the registration of
2,700,000 Common shares without par value of the Company (the "Shares") issuable
upon the exercise of options granted or to be granted under the Company's Stock
Option Plan (the "Plan"). In connection therewith, we have considered such
questions of law and have examined and relied upon such resolutions, records,
certificates of public officials and officers of the Company and other documents
we deemed necessary or appropriate to enable us to render the opinion express
below.

           Based on the foregoing, it is our opinion that the Shares will, upon
the exercise of such options in accordance with the terms of the Plan and the
receipt by the Company of the exercise price under such options for such Shares,
be validly issued and outstanding as fully paid and non-assessable shares.

           We hereby consent to the filing of this opinion as an exhibit to the
Registration Statement and to all references to our firm included in or made a
part of the Registration Statement.


                                        Yours Truly,


                                        /s/ McCARTHY TETRAULT
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7374 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7374

 To designate the facility of the United States Postal Service located 
at 500 Sergeant Gonzales Drive in Fort Davis, Texas, as the ``Sergeant 
                 Manuel Sillas Gonzales Post Office''.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 15, 2024

   Mr. Tony Gonzales of Texas (for himself, Mr. Fallon, Mr. Vicente 
Gonzalez of Texas, Mr. Cloud, Mrs. Fletcher, and Mr. Veasey) introduced 
 the following bill; which was referred to the Committee on Oversight 
                           and Accountability

_______________________________________________________________________

                                 A BILL

 
 To designate the facility of the United States Postal Service located 
at 500 Sergeant Gonzales Drive in Fort Davis, Texas, as the ``Sergeant 
                 Manuel Sillas Gonzales Post Office''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SERGEANT MANUEL SILLAS GONZALES POST OFFICE.

    (a) Designation.--The facility of the United States Postal Service 
located at 500 Sergeant Gonzales Drive in Fort Davis, Texas, shall be 
known and designated as the ``Sergeant Manuel Sillas Gonzales Post 
Office''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Sergeant 
Manuel Sillas Gonzales Post Office''.
                                 <all>
```
#### § 212.2 What is current good manufacturing practice for PET drugs?

Current good manufacturing practice for PET drugs is the minimum requirements for the methods to be used in, and the facilities and controls used for, the production, quality assurance, holding, or distribution of PET drugs intended for human use. Current good manufacturing practice is intended to ensure that each PET drug meets the requirements of the act as to safety and has the identity and strength, and meets the quality and purity characteristics, that it is supposed to have.
6/9/2014 10:15 AM Att. 007 Processing and Use Operations at Submitter’s Facility
<TABLE> <S> <C>

<ARTICLE>          5
<LEGEND>           THIS SCHEDULE CONTAINS SUMMARY FINANCIAL
                   INFORMATION EXTRACTED FROM THE COMPANY'S
                   UNAUDITED FINANCIAL STATEMENTS AS OF AND
                   FOR THE PERIOD ENDING SEPTEMBER 28, 1996,
                   AND IS QUALIFIED IN ITS ENTIRETY BY 
                   REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
<MULTIPLIER>       1,000
<PERIOD-TYPE>      9-MOS
<FISCAL-YEAR-END>  DEC-28-1996
<PERIOD-START>     DEC-31-1995
<PERIOD-END>       SEP-28-1996


<CASH>                                              8,214
<SECURITIES>                                            0
<RECEIVABLES>                                      64,147
<ALLOWANCES>                                          204
<INVENTORY>                                        57,573
<CURRENT-ASSETS>                                  145,193
<PP&E>                                             92,875
<DEPRECIATION>                                     24,741
<TOTAL-ASSETS>                                    326,030
<CURRENT-LIABILITIES>                             145,148
<BONDS>                                                 0
<COMMON>                                           31,016
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                             0
<OTHER-SE>                                        117,086
<TOTAL-LIABILITY-AND-EQUITY>                      326,030
<SALES>                                           723,374
<TOTAL-REVENUES>                                  723,374
<CGS>                                             610,524
<TOTAL-COSTS>                                     610,524
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                  1,637
<INCOME-PRETAX>                                    53,339
<INCOME-TAX>                                       20,500
<INCOME-CONTINUING>                                32,839
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                       32,839
<EPS-PRIMARY>                                        0.99
<EPS-DILUTED>                                        0.99



</TABLE>
#### § 211.204 Returned drug products.

Returned drug products shall be identified as such and held. If the conditions under which returned drug products have been held, stored, or shipped before or during their return, or if the condition of the drug product, its container, carton, or labeling, as a result of storage or shipping, casts doubt on the safety, identity, strength, quality or purity of the drug product, the returned drug product shall be destroyed unless examination, testing, or other investigations prove the drug product meets appropriate standards of safety, identity, strength, quality, or purity. A drug product may be reprocessed provided the subsequent drug product meets appropriate standards, specifications, and characteristics. Records of returned drug products shall be maintained and shall include the name and label potency of the drug product dosage form, lot number (or control number or batch number), reason for the return, quantity returned, date of disposition, and ultimate disposition of the returned drug product. If the reason for a drug product being returned implicates associated batches, an appropriate investigation shall be conducted in accordance with the requirements of § 211.192. Procedures for the holding, testing, and reprocessing of returned drug products shall be in writing and shall be followed.
**Exhibit 23.1**
Consent of Independent Registered Public Accounting Firm
We consent to theincorporation by reference in the following Registration Statements of our reportsdated February 28, 2005, with respect to the consolidated financial statements of IndependenceCommunity Bank Corp., Independence Community Bank Corp. management’s assessment of theeffectiveness of internal control over financial reporting, and the effectiveness of internalcontrol over financial reporting of Independence Community Bank Corp, included in the Form 10-K forthe year ended December 31, 2004:
Form S-8 No. 333-50987, pertaining to the Independence Community Bank          401(k) Savings Plan in RSI Retirement Trust
Form S-8 No. 333-74055, pertaining to the 1998 Stock Option Plan
Form S-8 No. 333-85981, pertaining to the Stock Options Assumed in          Acquisition of Broad National Bancorporation
Form S-8 No. 333-95767, pertaining to the Stock Options Assumed in          Acquisition of Statewide Financial Corp.
Form S-8 No. 333-60204, pertaining to the Directors’ Fiscal 2002 Stock          Retainer Plan
Form S-8 No. 333-83330, pertaining to the Directors’ Fee Plan
Form S-8 No. 333-106193, pertaining to the 2002 Stock Incentive Plan, as amended
Form S-3 No. 333-100897, pertaining to the common stock available for          resale by Meridian Capital Group, LLC
Form S-8 No. 333-111562, pertaining to the stock options assumed in the acquisition          of Staten Island Bancorp, Inc.              /s/ Ernst & Young LLP         
New York, New York
<TABLE> <S> <C>

<ARTICLE> 9
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
REGISTRANT'S FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 1998 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                          16,593
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                 4,750
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                      1,760
<INVESTMENTS-CARRYING>                          44,484
<INVESTMENTS-MARKET>                            44,525
<LOANS>                                        222,632
<ALLOWANCE>                                      3,301
<TOTAL-ASSETS>                                 297,637
<DEPOSITS>                                     248,965
<SHORT-TERM>                                    17,981
<LIABILITIES-OTHER>                              2,466
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           711
<OTHER-SE>                                      27,514
<TOTAL-LIABILITIES-AND-EQUITY>                 297,637
<INTEREST-LOAN>                                  5,019
<INTEREST-INVEST>                                  707
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                 5,772
<INTEREST-DEPOSIT>                               1,566
<INTEREST-EXPENSE>                               1,769
<INTEREST-INCOME-NET>                            4,003
<LOAN-LOSSES>                                      270
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  4,614
<INCOME-PRETAX>                                    (9)
<INCOME-PRE-EXTRAORDINARY>                        (10)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (10)
<EPS-PRIMARY>                                    (.01)
<EPS-DILUTED>                                    (.01)
<YIELD-ACTUAL>                                    5.99
<LOANS-NON>                                      3,910
<LOANS-PAST>                                        44
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 3,198
<CHARGE-OFFS>                                      178
<RECOVERIES>                                        11
<ALLOWANCE-CLOSE>                                3,301
<ALLOWANCE-DOMESTIC>                             3,301
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                            534
        

</TABLE>
**Exhibit32.1**

 

**CERTIFICATIONPURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

The undersigned officer of Altris Software, Inc. (the “Company”) herebycertifies to his knowledge that the Company’s quarterly report on Form 10-Q forthe period ended December 31, 2003 (the “Report”), as filed with theSecurities and Exchange Commission on the date hereof, fully complies with therequirements of Section 13(a) or 15(d), as applicable, of the SecuritiesExchange Act of 1934, as amended, and that the information contained in theReport fairly presents, in all material respects, the financial condition andresults of operations of the Company.  This certification is providedsolely pursuant to 18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed tobe a part of the Report or “filed” for any purpose whatsoever.

 
| Dated:  February 13, 2004 |
|-------------------------------------|
|                                |
| /s/ Carl Mostert                    |   |
|                                |
| Carl Mostert                        |
| Chief Executive Officer             |

 

 

A signed original of this written statement required bySection 906 has been provided to Altris Software, Inc. and will beretained by Altris Software, Inc. and furnished to the Securities and ExchangeCommission or its staff upon request.

 

----
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7158 Engrossed in House (EH)]

<DOC>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
118th CONGRESS
  2d Session
                                H. R. 7158

_______________________________________________________________________

                                 AN ACT

 
 To designate the facility of the United States Postal Service located 
  at 201 East Battles Road in Santa Maria, California, as the ``Larry 
                   Lavagnino Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. LARRY LAVAGNINO POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 201 East Battles Road in Santa Maria, California, shall be 
known and designated as the ``Larry Lavagnino Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Larry 
Lavagnino Post Office Building''.

            Passed the House of Representatives December 4, 2024.

            Attest:

                                                                 Clerk.
118th CONGRESS

  2d Session

                               H. R. 7158

_______________________________________________________________________

                                 AN ACT

 To designate the facility of the United States Postal Service located 
  at 201 East Battles Road in Santa Maria, California, as the ``Larry 
                   Lavagnino Post Office Building''.
```
#### § 820.61 Secretarial officer.

The Secretarial Officer who is primarily responsible for the activity to which a DOE Nuclear Safety Requirement relates may grant a temporary or permanent exemption from that requirement as requested by any person subject to its provisions; provided that, the Secretarial Officer responsible for environment, safety and health matters shall exercise this authority with respect to provisions relating to radiological protection of workers, the public and the environment. This authority may not be further delegated.
[No. 21097-5-II.

Division Two.

December 19, 1997.]

#### The State of Washington, *Respondent,*v. John Earl Waller, *Appellant.*

Appeal from a judgment of the Superior Court for Pierce County, No. 95-1-03635-1, Nile E. Aubrey, J., entered July 25, 1996. *Affirmed*by unpublished opinion per Morgan, J., concurred in by Seinfeld and Armstrong, JJ.
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1945 Vitamin B12. ( a ) Vitamin B12, also known as cyanocobalamin (C63H88CoN14O14P, CAS Reg. No. 68-0919-099), is produced commercially from cultures of *Streptomyces griseus.*
( b ) The ingredient meets the specifications of the Food Chemicals Codex, 3d Ed. (1981), p. 343, which is incorporated by reference. Copies are available from the National Academy Press, 2101 Constitution Ave. NW., Washington, DC 20418, or available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
( c ) In accordance with § 184.1(b)(1), the ingredient is used in food with no limitation other than current good manufacturing practice. The affirmation of this ingredient as generally recognized as safe (GRAS) as a direct human food ingredient is based upon the following current good manufacturing practice conditions of use: ( 1 ) The ingredient is used as a nutrient supplement as defined in § 170.3(o)(20) of this chapter.
( 2 ) The ingredient is used in food at levels not to exceed current good manufacturing practice. Vitamin B12 also may be used in infant formula in accordance with section 412(g) of the Federal Food, Drug, and Cosmetic Act (the act) or with regulations promulgated under section 412(a)(2) of the act.
( d ) Prior sanctions for this ingredient different from the uses established in this section do not exist or have been waived.
[50 FR 6341, Feb. 15, 1985]
Editorial Note on Part 172
Editorial Note: Nomenclature changes to part 172 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 172.140 Ethoxyquin. ( a ) Ethoxyquin (1,2-dihydro-6-ethoxy-2,2,4-trimethylquinoline) may be safely used as an antioxidant for preservation of color in the production of chili powder, paprika, and ground chili at levels not in excess of 100 parts per million.
( b ) In order to provide for the safe use of the additive in feed prepared in accordance with §§ 573.380 and 573.400 of this chapter, tolerances are established for residues of ethoxyquin in or on edible products of animals as follows:
5 parts per million in or on the uncooked fat of meat from animals except poultry. 3 parts per million in or on the uncooked liver and fat of poultry. 0.5 part per million in or on the uncooked muscle meat of animals. 0.5 part per million in poultry eggs. Zero in milk.
11TH COURT OF APPEALS

EASTLAND, TEXAS

JUDGMENT

Kenneth Kocher, * From the 350th District Court

of Taylor County,

Trial Court No. 14140-D.

Vs. No. 11-21-00288-CR * January 13, 2022

The State of Texas, * Per Curiam Memorandum Opinion

(Panel consists of: Bailey, C.J.,

Trotter, J., and Williams, J.)

This court has inspected the record in this cause and concludes that the appeal 

should be dismissed for want of jurisdiction. Therefore, in accordance with this 

court’s opinion, the appeal is dismissed.
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


           In connection with the Annual Report of LMIC, Inc. (the "Company") on
Form 10-KSB for the period ending December 31, 2003 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Luis P. Negrete,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:

                      (1) The Report fully complies with the requirements of
section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

                      (2) The information contained in the Report fairly
presents, in all material respects, the financial condition and results of
operations of the Company.



                                            /s/ Luis P. Negrete
                                            Luis P. Negrete
                                            Chief Executive Officer
                                            Acting Chief Financial Officer
                                            April 30, 2004